Compound ID | 1794
RX-04
Synonym(s): BV300
Class: Pyrrolocytosine
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Enterobacteriaceae and Acinetobacter, binding to the protein 50S ribosomal subunit |
| Description: | Synthetic compound. Acquired from Melinta Therapeutics |
| Institute where first reported: | Bioversys AG (Melinta Therapeutics formerly Rib-X Pharmaceutical) |
| Year first mentioned: | 2018 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.